Quinolinyl ether or thioether tetrazoles as agents for the treatment of hypersensitive ailments
US4874769A · kind A · utility
13Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 1988 |
| Grant date | Oct 17, 1989 |
| Priority date | — |
| Expiry date | Jan 5, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to certain quinolyl ether and thioether tetrazoles and their use as valuable pharmaceutical agents for the treatment of hypersensitive ailments, particularly as lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and antiallergic properties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.